CONTACT
CONTACT

NEWS

The Biodesign Story of Titan SGS®

SBI_LI_Biodesign

From a full-length gastric clamp to the Titan SGS, a full-length gastric stapler, our medical device innovations are focused on making bariatric surgery significantly safer and more repeatable.

We launched in 2014 to work on meeting the unmet clinical needs surrounding sleeve gastrectomy pouch creation with the end goal to lower the intervention threshold for the surgical treatment of obesity.

Read the full history written by Jonathon Thompson, MD, FACS, FASMBS, Founder and Chief Medical Officer, Standard Bariatrics, in this month’s issue of Bariatric Times.

Download the PDF here.

RECENT NEWS

NEW Study

Titan SGS™ Stapler linked to improved 1 year post-op GERD outcomes in new retrospective study. 

Ying L, Rutledge R, Butensky S, Farinas Lugo D, Morton JM, Ringold F. Does stapling platform influence robotic sleeve gastrectomy postoperative outcomes? Obes Surg. 2025;35(4). doi:10.1007/s11695-025-07855-z

 

Dr. Morton and Dr. Ringold, two of the authors of the study, are paid consultants of Teleflex Incorporated.

View the Study

New propensity matched retrospective study reports perioperative outcomes of the Titan SGSTM Stapler.

View the Study

Thank you for joining the community of bariatric surgeons interested in the Titan SGS®.

We'll connect with you soon.

REQUEST TRAINING*

Please fill out the form below to receive training information.

*Titan SGS® is cleared for use by the U.S. Food and Drug Administration (FDA). It is currently only available for purchase and use in the United States of America (USA).